Cell Marque, Glypican-3 (1G12 Mab), 7 mL, REF PA0800, IVD, The antibody is intended for in vitro diagnostic (IVD) use. Glypican-3 (1G12) Mouse Monoclonal Primary Antibody is intended for laboratory use in the detection of the Glypican-3 protein in formalin-fixed, paraffin-embedded tissue stained in qualitative immunohistochemistry (IHC) testing.
Published September 20, 2017 · Recall initiated: July 14, 2017
Summary
FDA records medical device Class II recall Z-3121-2017, published September 20, 2017 and initiated July 14, 2017. Recalling firm: Leica Biosystems Richmond Inc.; Status: Terminated; Reported quantity: 3; Lot: Product Code PA0800, Lot No. 46232, Exp. Date 06/04/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Leica Biosystems Richmond Inc.
- Distributor
- Nationwide Distribution to AR, AZ, CA, CT, FL, GA, IL, IN, KY, LA, MI, MN, NC, NH, NV, NY, OR, PA, SC, TN, TX, VA, and WI.
- Lot
- Product Code PA0800, Lot No. 46232, Exp. Date 06/04/2019
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACell Marque, PAX8 (MRQ-50 Mab.), 7 mL, REF PA0808, IVD, This antibody is intended for in vitro diagnosticSeptember 20, 2017
- FDACell Marque, Podoplanin (D2-40 Mab), 7 mL, REF PA0796, IVD, The antibody is intended for in vitro diagnosticSeptember 20, 2017
- FDACell Marque, Napsin A (MRQ-60 Mab.), 7 mL, REF PA0805, IVD, The antibody is intended for in vitro diagnosticSeptember 20, 2017
- FDACell Marque, SOX-10 (Polyclonal), 7 mL, REF PA0813, IVD, This antibody is intended for in vitro diagnosticSeptember 20, 2017
- FDASekisui Diagnostics Sekure Chemistry Acetaminophen L3K , Ref. 506-30. The firm names on the label are SekisuiSeptember 20, 2017
- FDABD Needle 22GA 1-1/2in SafetyGlide(TM) Non Sterile, Bulk, REF 301701 The BD SafetyGlide(TM) needle is intendedSeptember 20, 2017
Questions about this recall
Was Cell Marque, Glypican-3 (1G12 Mab), 7 mL, REF PA0800, IVD, The antibody is intended for in vitro diagnostic (IVD) use. Glypican-3 (1G12) Mouse Monoclonal Primary Antibody is intended for laboratory use in the detection of the Glypican-3 protein in formalin-fixed, paraffin-embedded tissue stained in qualitative immunohistochemistry (IHC) testing. recalled?
Yes. FDA published recall Z-3121-2017 on September 20, 2017. Reported hazard: A delay in transit may have contributed to nonconformity as the product was stored outside of defined shipping and handling temperature requirements.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail